Cancer Drug Parity Act of 2025

HR 4101 (119th Congress) is federal legislation introduced in the U.S. House of Representatives on June 24, 2025. Sponsored by Rep. Grothman, Glenn [R-WI-6]. Current status: Referred to the House Committee on Education and Workforce. (2025-06-24).